col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


27 Results       Page 1

 [1] 
Springer Science and Business Media LLC: Nature Cancer
  original article Date Title Authors   All Authors
1 [GO] 2025―Jan―02 The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis Richa Shah, Nader Mounir Hanna, Ching Ee Loo, Michael David, Allini Mafra, Hanna Fink, et al. (+22)
2 [GO] 2023―Jan―31 Two approaches to tackling COVID-19 in patients with blood cancer Ratna Wijaya, Sean H. Lim
3 [GO] 2022―Dec―29 Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial Claudia M. Denkinger, Maike Janssen, Ulrike Schäkel, Julia Gall, Albrecht Leo, Patrick Stelmach, et al. (+48)
4 [GO] 2022―Dec―21 Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma Andrea Keppler-Hafkemeyer, Christine Greil, Paul R. Wratil, Khalid Shoumariyeh, Marcel Stern, Annika Hafkemeyer, et al. (+23)
5 [GO] 2022―Dec―20 Cancer research in the midst of COVID-19 Karl Gruber
6 [GO] 2022―Jul―15 Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy Thomas Walle, Sunanjay Bajaj, Joscha A. Kraske, Thomas Rösner, Christiane S. Cussigh, Katharina A. Kälber, et al. (+50)
7 [GO] 2022―Jun―17 Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy Thomas Walle, Sunanjay Bajaj, Joscha A. Kraske, Thomas Rösner, Christiane S. Cussigh, Katharina A. Kälber, et al. (+52)
8 [GO] 2022―May―27 A needed boost against COVID-19 in lymphoma Ariel Fromowitz, Amit Verma
9 [GO] 2022―May―11 Impaired immune responses in blood cancers improved by third COVID-19 vaccine dose
10 [GO] 2022―Apr―04 Outcomes of COVID-19 and risk factors in patients with cancer Manju Sengar, Girish Chinnaswamy, Priya Ranganathan, Apurva Ashok, Shilpushp Bhosale, Sanjay Biswas, et al. (+46)
11 [GO] 2022―Mar―25 Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study Sean H. Lim, Beth Stuart, Debora Joseph-Pietras, Marina Johnson, Nicola Campbell, Adam Kelly, et al. (+28)
12 [GO] 2022―Feb―08 Author Correction: The immuno-oncological challenge of COVID-19 Lisa Derosa, Cléa Melenotte, Franck Griscelli, Bertrand Gachot, Aurélien Marabelle, Guido Kroemer, Laurence Zitvogel
13 [GO] 2021―Dec―21 COVID-19 and cancer care in India C. S. Pramesh, Girish Chinnaswamy, Manju Sengar, Priya Ranganathan, Rajendra Badwe
14 [GO] 2021―Dec―16 Capturing adaptive immunity against SARS-CoV-2 in patients with cancer Hendrik Luxenburger, Robert Thimme
15 [GO] 2021―Oct―27 Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study Annika Fendler, Lewis Au, Scott T. C. Shepherd, Fiona Byrne, Maddalena Cerrone, Laura Amanda Boos, et al. (+92)
16 [GO] 2021―Oct―27 Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study Annika Fendler, Scott T. C. Shepherd, Lewis Au, Katalin A. Wilkinson, Mary Wu, Fiona Byrne, et al. (+90)
17 [GO] 2021―Mar―22 Patterns of seroconversion for SARS-CoV-2 IgG in patients with malignant disease and association with anticancer therapy Astha Thakkar, Kith Pradhan, Shawn Jindal, Zhu Cui, Bradley Rockwell, Akash Pradip Shah, et al. (+7)
18 [GO] 2021―Feb―03 Eliminating cervical cancer in the COVID-19 era Ophira Ginsburg, Partha Basu, Sharon Kapambwe, Karen Canfell
19 [GO] 2020―Dec―16 Tackling the shadow pandemic
20 [GO] 2020―Oct―09 A global effort to understand the riddles of COVID-19 and cancer Vivek Subbiah
21 [GO] 2020―Oct―02 The immuno-oncological challenge of COVID-19 Lisa Derosa, Cléa Melenotte, Franck Griscelli, Bertrand Gachot, Aurélien Marabelle, Guido Kroemer, Laurence Zitvogel
22 [GO] 2020―Sep―22 Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort Laurence Albiges, Stéphanie Foulon, Arnaud Bayle, Bertrand Gachot, Fanny Pommeret, Christophe Willekens, et al. (+25)
23 [GO] 2020―Jul―31 SARS-CoV-2 infection in the Italian Veneto region: adverse outcomes in patients with cancer Massimo Rugge, Manuel Zorzi, Stefano Guzzinati
24 [GO] 2020―May―29 Rethinking cancer clinical trials for COVID-19 and beyond Gary J. Doherty, Mehmet Goksu, Bruno H. R. de Paula
25 [GO] 2020―May―20 The impact of the COVID-19 pandemic on cancer care Mike Richards, Michael Anderson, Paul Carter, Benjamin L. Ebert, Elias Mossialos
26 [GO] 2020―Apr―21 Crowdsourcing a crisis response for COVID-19 in oncology Aakash Desai, Jeremy Warner, Nicole Kuderer, Mike Thompson, Corrie Painter, Gary Lyman, Gilberto Lopes
27 [GO] 2020―Apr―09 On being human in the face of a pandemic
 [1] 

27 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec